Skip to main content

RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

Objective

Recently, a new class of “living drugs” has been developed – Advanced Therapies which aim to transform the current focus of “treatment of disease” into one that concentrates on “restoration of health” with promising results in a broad field of Regenerative Medicine, including targeted immune reconstitution for cancer treatment. Advanced Therapies are game changing in Health Care and have a rapidly expanding market size of approximately 12 and 50 bn € expected by 2020 and 2030, respectively. There is great value in European science and technology on Advanced Therapies but Europe has been losing ground because of scattered and underpowered efforts. If Europe wants a leading role in this emerging field in the future, a mission-driven approach is required to make the transforming promise of Advanced Therapies a reality. The development of new Advanced Therapy products and their implementation in clinical practice will enhance the value-based outcome of patients. Measurable by having dozens of premier-league Advanced Therapy Products “discovered & made in Europa” by 2030 and beyond. Bringing affordable, standard-of-care for currently incurable diseases which are accessible for every European citizen who need it to RESTORE Health. We propose a mission-driven programme led by the candidate LSRI RESTORE, aiming to build a coordinated, financially strong European partnership between different areas of interest and cross-sectors involving academia, industry, regulatory authorities, health care, patient organisations, and public society.
In order to guarantee a smart start of the LSRI from 2021 onwards, the preparation phase aims to involve the growing RESTORE community even more closely in working groups on identified tasks and to jointly complete the RESTORE agenda for Research & Innovation Actions as well as Coordination & Support Actions.
The deliverables of RESTORE will allow Europe to gain a world leading health position within this emerging field.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/clinical medicine/oncology/cancer

Call for proposal

H2020-FETFLAG-2018-01
See other projects for this call

Funding Scheme

CSA - Coordination and support action

Coordinator

CHARITE - UNIVERSITAETSMEDIZIN BERLIN
Address
Chariteplatz 1
10117 Berlin
Germany
Activity type
Higher or Secondary Education Establishments
EU contribution
€ 105 000

Participants (10)

UNIVERSITAT ZURICH
Switzerland
EU contribution
€ 52 500
Address
Ramistrasse 71
8006 Zurich
Activity type
Higher or Secondary Education Establishments
CELL THERAPY CATAPULT LIMITED
United Kingdom
EU contribution
€ 52 500
Address
12Th Floor Tower Wing Guy's Hospital Great Maze Pond
SE1 9RT London
Activity type
Research Organisations
TISSUSE GMBH
Germany
EU contribution
€ 15 000
Address
Oudenarder Strasse 16
13347 Berlin
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
PLURISTEM LTD
Israel
EU contribution
€ 15 000
Address
Matam Industrial Park Bldg 20
31905 Haifa
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
MILTENYI BIOTEC GMBH

Participation ended

Germany
EU contribution
€ 8 750
Address
Friedrich Ebert Strasse 68
51429 Bergish Gladbach
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
France
EU contribution
€ 52 500
Address
Rue De Tolbiac 101
75654 Paris
Activity type
Research Organisations
INNOVATION ACTA S.R.L.
Italy
EU contribution
€ 587 500
Address
Via D.a. Azuni, 9
00196 Roma
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
FONDAZIONE TELETHON
Italy
EU contribution
€ 52 500
Address
Via Varese 16/B
00185 Roma
Activity type
Research Organisations
UNIVERSIDADE DO MINHO
Portugal
EU contribution
€ 52 500
Address
Largo Do Paco
4704 553 Braga
Activity type
Higher or Secondary Education Establishments
MILTENYI BIOTEC BV & CO KG
Germany
EU contribution
€ 6 250
Address
Friedrich Ebert Strasse 68
51429 Bergisch Gladbach
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)